Citigroup’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-716,402
| Closed | -$82K | – | 7951 |
|
|
2018
Q4 | $82K | Sell |
716,402
-316,427
| -31% | -$208K | ﹤0.01% | 5835 |
|
|
2018
Q3 | $1.76M | Buy |
1,032,829
+123,239
| +14% | +$221K | ﹤0.01% | 2883 |
|
|
2018
Q2 | $1.58M | Buy |
909,590
+205,976
| +29% | +$356K | ﹤0.01% | 2905 |
|
|
2018
Q1 | $1.29M | Sell |
703,614
-1,634,553
| -70% | -$3.45M | ﹤0.01% | 3029 |
|
|
2017
Q4 | $5.21M | Buy |
2,338,167
+555,342
| +31% | +$1.38M | ﹤0.01% | 1800 |
|
|
2017
Q3 | $5.17M | Buy |
1,782,825
+874,427
| +96% | +$2.98M | ﹤0.01% | 1732 |
|
|
2017
Q2 | $4.04M | Buy |
908,398
+869,762
| +2,251% | +$3.59M | ﹤0.01% | 1889 |
|
|
2017
Q1 | $180K | Sell |
38,636
-378,574
| -91% | -$2.2M | ﹤0.01% | 4750 |
|
|
2016
Q4 | $2.54M | Sell |
417,210
-371,971
| -47% | -$1.94M | ﹤0.01% | 2654 |
|
|
2016
Q3 | $4.35M | Buy |
789,181
+162,047
| +26% | +$759K | ﹤0.01% | 1789 |
|
|
2016
Q2 | $2.38M | Sell |
627,134
-5,793
| -0.9% | -$19.6K | ﹤0.01% | 2211 |
|
|
2016
Q1 | $1.75M | Sell |
632,927
-217,280
| -26% | -$787K | ﹤0.01% | 2662 |
|
|
2015
Q4 | $4.82M | Buy |
850,207
+238,600
| +39% | +$1.45M | ﹤0.01% | 1728 |
|
|
2015
Q3 | $3.24M | Buy |
611,607
+595,103
| +3,606% | +$4.61M | ﹤0.01% | 2038 |
|
|
2015
Q2 | $137K | Sell |
16,504
-1,475
| -8% | -$7.15K | ﹤0.01% | 4754 |
|
|
2015
Q1 | $83K | Sell |
17,979
-19,617
| -52% | -$63.8K | ﹤0.01% | 5168 |
|
|
2014
Q4 | $115K | Buy |
37,596
+10,909
| +41% | +$32.3K | ﹤0.01% | 5139 |
|
|
2014
Q3 | $75K | Sell |
26,687
-4,922
| -16% | -$17.9K | ﹤0.01% | 5000 |
|
|
2014
Q2 | $129K | Sell |
31,609
-10,825
| -26% | -$46K | ﹤0.01% | 4488 |
|
|
2014
Q1 | $225K | Sell |
42,434
-21,932
| -34% | -$123K | ﹤0.01% | 4216 |
|
|
2013
Q4 | $357K | Buy |
64,366
+18,597
| +41% | +$80.2K | ﹤0.01% | 4122 |
|
|
2013
Q3 | $207K | Buy |
45,769
+13,248
| +41% | +$59.4K | ﹤0.01% | 4126 |
|
|
2013
Q2 | $138K | Buy |
+32,521
| New | +$163K | ﹤0.01% | 4582 |
|
Other funds holding SGYP
Citigroup's SGYP Position: Q1 2019 in Review
Citigroup sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 716,402 shares — an estimated $82K sold.
Citigroup first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $5.21M in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Citigroup reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Citigroup sold 716,402 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $82K.
- Citigroup first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Citigroup's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.21M in Q4 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.